Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Donato

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Experimental Cell Research|March 17, 2004
Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cellsNicholas J Donato, Jim Klostergaard
Breast Cancer Research : BCR|January 22, 2015
Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancerAnupama Pal, Nicholas J Donato
Leukemia & Lymphoma|February 9, 2011
Chronic myeloid leukemia stem cells and developing therapiesNicholas J Donato, Luke F Peterson
Cancer Research|August 31, 2014
Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancerAnupama Pal, Matthew A Young, Nicholas J Donato
Journal of Cellular Physiology|May 12, 2005
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cellsFaye M Johnson, Babita Saigal, Nicholas J Donato
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effectsFaye M Johnson, Babita Saigal, Hai Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cellsFaye M Johnson, Babita Saigal, Moshe Talpaz, et al.
Journal of Experimental Therapeutics & Oncology|April 23, 2005
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylateFaye M Johnson, Peiying Yang, Robert A Newman, et al.
Cancer Research|April 19, 2007
Degrasyn activates proteasomal-dependent degradation of c-MycGeoffrey Bartholomeusz, Moshe Talpaz, William Bornmann, et al.
Oncotarget|October 25, 2019
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cellsHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Experimental Cell Research|March 17, 2004
Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cellsNicholas J Donato, Jim Klostergaard
Breast Cancer Research : BCR|January 22, 2015
Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancerAnupama Pal, Nicholas J Donato
Leukemia & Lymphoma|February 9, 2011
Chronic myeloid leukemia stem cells and developing therapiesNicholas J Donato, Luke F Peterson
Cancer Research|August 31, 2014
Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancerAnupama Pal, Matthew A Young, Nicholas J Donato
Journal of Cellular Physiology|May 12, 2005
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cellsFaye M Johnson, Babita Saigal, Nicholas J Donato
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effectsFaye M Johnson, Babita Saigal, Hai Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cellsFaye M Johnson, Babita Saigal, Moshe Talpaz, et al.
Journal of Experimental Therapeutics & Oncology|April 23, 2005
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylateFaye M Johnson, Peiying Yang, Robert A Newman, et al.
Cancer Research|April 19, 2007
Degrasyn activates proteasomal-dependent degradation of c-MycGeoffrey Bartholomeusz, Moshe Talpaz, William Bornmann, et al.
Oncotarget|October 25, 2019
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cellsHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Pageof 4